The role of group IIA secretory phospholipase A2 (sPLA2-IIA) as a biomarker for the diagnosis of sepsis and bacterial infection in adults-A systematic review

被引:41
|
作者
Tan, Toh Leong [1 ,2 ]
Goh, Yew Yip [1 ,2 ]
机构
[1] Univ Kebangsaan Malaysia, Fac Med, Dept Emergency Med, Kuala Lumpur, Malaysia
[2] Univ Kebangsaan Malaysia, Med Ctr, Dept Emergency Med, Kuala Lumpur, Malaysia
来源
PLOS ONE | 2017年 / 12卷 / 07期
关键词
C-REACTIVE PROTEIN; INFLAMMATORY RESPONSE; SERUM PHOSPHOLIPASE; GENE-EXPRESSION; SYNOVIAL-FLUID; ORGAN FAILURE; A(2); ATHEROSCLEROSIS; IDENTIFICATION; PROCALCITONIN;
D O I
10.1371/journal.pone.0180554
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Introduction This paper investigates the role of Group II Secretory Phospholipase A2 (sPLA2-IIA) as a biomarker for the diagnosis of sepsis and bacterial infection in adults. Sepsis and bacterial infection are common problems encountered by patients in the hospital and often carry adverse outcomes if not managed early. Methods Two independent reviewers conducted a comprehensive search using Ovid MEDLINE published from years 1993 to 2016 and SCOPUS published from year 1985 to 2017 to screen for relevant studies. The main inclusion criteria included adult subjects, patients with suspected or confirmed signs of infection and relevant outcomes which looked into the role of sPLA2-IIA in detecting the presence of sepsis and bacterial infection in the subjects. Results and discussion Four studies met the inclusion criteria. SPLA2-IIA was found to be effective in detecting the presence of sepsis and bacterial infection in adults. The levels of serum sPLA2-IIA also correlated well with the presence of sepsis and bacterial infection. Conclusion This systematic review highlights the role of sPLA2-IIA as a reliable tool to diagnose sepsis and bacterial infection in adult patients. Nonetheless, further studies should be done in the future to provide more compelling evidence on its application in the clinical setting.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] Utility of Group II Secretory Phospholipase A2 (sPLA2-IIA) as a Biomarker for Infection in Patients Admitted to the Intensive Care Unit
    Shaller, B.
    Asuni, T.
    Marmor, M. B.
    Zweitzig, D.
    Torres, J.
    Cichonski, K.
    Ryan, D.
    Rogers, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [2] CD64 and Group II Secretory Phospholipase A2 (sPLA2-IIA) as Biomarkers for Distinguishing Adult Sepsis and Bacterial Infections in the Emergency Department
    Tan, Toh Leong
    Ahmad, Nurul Saadah
    Nasuruddin, Dian Nasriana
    Ithnin, Azlin
    Arifin, Khaizurin Tajul
    Zaini, Ida Zarina
    Ngah, Wan Zurinah Wan
    PLOS ONE, 2016, 11 (03):
  • [3] Group IIa secretory phospholipase A2 (sPLA2IIa) and progression in patients with lung cancer
    Wang, M.
    Hao, F-Y.
    Wang, J-G.
    Xiao, W.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2014, 18 (18) : 2648 - 2654
  • [4] Characterization of secretory type IIA phospholipase A2 (sPLA2-IIA) as a glycyrrhizin (GL)-binding protein and the GL-Induced inhibition of the CK-II-mediated stimulation of sPLA2-IIA activity in vitro
    Shimoyama, Y
    Sakamoto, R
    Akaboshi, T
    Tanaka, M
    Ohtsuki, K
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2001, 24 (09) : 1004 - 1008
  • [5] Group IIA secretory phospholipase A2 (sPLA2-IIA) activation contributes to apoptosis after NMDA-receptor over-activation in primary neurons
    Chiricozzi, E.
    Fernandez-Fernandez, S.
    Almeida, A.
    Bolanos, J. P.
    Goracci, G.
    JOURNAL OF NEUROCHEMISTRY, 2009, 110 : 20 - 20
  • [6] Serum secretory phospholipase A2-IIa (sPLA2-IIA) levels in patients surviving acute myocardial infarction
    Xin, H.
    Chen, Z. -Y.
    Lv, X. -B.
    Liu, S.
    Lian, Z. -X.
    Cai, S. L.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2013, 17 (08) : 999 - 1004
  • [7] Measurement of a Novel Biomarker, Secretory Phospholipase A2 Group IIA as a Marker of Sepsis: A Pilot Study
    Berg, Elena
    Paukovits, Janel
    Axelband, Jennifer
    Trager, Jonathan
    Ryan, Dina
    Cichonski, Kathleen
    Kopnitsky, Mark
    Zweitzig, Daniel
    Jeanmonod, Rebecca
    JOURNAL OF EMERGENCIES TRAUMA AND SHOCK, 2018, 11 (02) : 135 - 139
  • [8] Inhibitors of secretory phospholipase A2 group IIA
    Reid, RC
    CURRENT MEDICINAL CHEMISTRY, 2005, 12 (25) : 3011 - 3026
  • [9] Expression profile of multiple secretory phospholipase A2 isoforms in the rat CNS: Enriched expression of sPLA2-IIA in brainstem and spinal cord
    Ma, May-Thu
    Nevalainen, Limo J.
    Yeo, Jin-Fei
    Ong, Wei-Yi
    JOURNAL OF CHEMICAL NEUROANATOMY, 2010, 39 (04) : 242 - 247
  • [10] High sPLA2-IIA level is associated with eicosanoid metabolism in patients with bacterial sepsis syndrome
    Ahmad, Nurul Saadah
    Tan, Toh Leong
    Arifin, Khaizurin Tajul
    Ngah, Wan Zurinah Wan
    Yusof, Yasmin Anum Mohd
    PLOS ONE, 2020, 15 (03):